COPD Flashcards

1
Q

Which two questionnaires are used to assess a patient’s COPD symptoms?

A

MRC and CAT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does the MRC questionnaire assess?

A

Dyspnoea (breathlessness).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does the CAT questionnaire assess?

A

General COPD symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is one major drawback to using inhaled corticosteroids in COPD?

A

Greater risk of URTIs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In the NICE guidelines, what does ‘features suggesting steroid responsiveness’ mean?

A

High eosinophil count.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the first line pharmacological treatment suggested by NICE for the treatment of COPD?

A

Offer SABA or SAMA to use as needed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which two organisations provide guidelines for the treatment of patients with COPD?

A

NICE and GOLD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

If a patient with COPD is limited by symptoms or has exacerbations despite treatment, and has no features suggesting asthma or steroid responsiveness, what treatment should be offered?

A

Offer LAMA and LABA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If a patient with COPD has been given a LAMA and a LABA and still has symptoms that adversely impact their quality of life, what should be considered?

A

A 3-month trial of LABA, LAMA and ICS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

If a patient with COPD is limited by symptoms or has exacerbations despite treatment, and has features suggesting asthma or steroid responsiveness, what treatment should be considered?

A

LABA and ICS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

If a patient with COPD and asthmatic or steroid responsiveness features has been given a LABA and an ICS but still has symptoms adversely impacting their QOL or they have exacerbations (1 severe or 2 moderate) in a year, what should be considered?

A

LAMA, LABA and ICS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some causes of exacerbations in COPD?

A

URTI. Exposure to certain compounds (pollution). Severe allergic responses. Weather changes. Overexertion. Lack of sleep. Stress/anxiety.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some factors which influence the progression and development of COPD?

A

Diet and nutrition. Low socioeconomic status. Physical activity. Genetics. Lung growth and development in gestation. Frequent RTIs in childhood. Age. Asthma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is diagnosis and initial assessment of COPD made?

A

Spirometry. Incidental findings from other tests. Sputum culture. Bronchodilator reversibility test. History taking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How frequent is follow up carried out for patients with stages 1 to 3 COPD?

A

Every year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How frequent is follow up carried out for patients with stage 4 COPD?

A

At least twice a year.

17
Q

What is the greatest cause of COPD?

A

Smoking.

18
Q

Describe cor pulmonale.

A

Abnormal enlargement of the right side of the heart due to disease of the lungs or pulmonary blood vessels.

19
Q

If a patient with COPD presents with cor pulmonale, what course of action should be taken?

A

Referral to a specialist.

20
Q

How is peripheral oedema secondary to COPD treated?

A

With furosemide.

21
Q

If a patient with a COPD presents with abnormal BMI, what course of action should be taken?

A

Referral to dietician.

22
Q

If a patient with COPD presents with a BMI lower than 18.5, what course of action would a dietician take?

A

Nutritional supplementation.

23
Q

If a patient with COPD presents with a BMI higher than 25, what course of action would a dietician take?

A

Weight loss.

24
Q

What may be used to treat a chronic productive cough in a patient with COPD?

A

A mucolytic e.g. carbocisteine.

25
Q

If a patient presents with severe COPD and hypoxaemia, what treatment is required?

A

Long term oxygen therapy (15 hours a day).

26
Q

Describe the treatment required when a patient presents with an exacerbation of COPD.

A

Nebulised bronchodilators (ipratropium or salbutamol). Antibiotics if suspected infection. 7–14-day course of oral corticosteroids if breathlessness interferes with day-to-day life.